Peptides 101: What They Are and How They Work

At the simplest level, a peptide is a short chain of amino acids. Amino acids are the building blocks your body uses to make proteins.

Amino acids → peptides → larger proteins.

The line between a peptide and a protein isn't a specific number you can memorise. Generally, peptides are shorter chains and proteins are larger, more complex molecules that fold into three-dimensional shapes. Biology isn't always that clean.

Here is the part that matters: your body already produces thousands of peptides. Some act as signals. Some interact with receptors. Some are involved in metabolism, repair, immune signalling, appetite, growth. So "peptides" is not one kind of substance — it's an enormous family of molecules that behave very differently from each other.

This is the easiest way I've found to hold it in my head.

Imagine the body as a communication network:

• Cells are houses
• Receptors are locks
• Peptides are messages, or keys

A peptide travels through the body and meets a particular receptor. When the right peptide meets the right receptor, it triggers a signal, and that signal tells the cell to do something — release this, produce that, turn this pathway up, turn that one down.

The important part: the peptide usually isn't doing the job itself. It's sending the message that makes the cell respond.

A peptide binds. The receptor activates. The cell starts signalling internally. Something changes.

Peptide → receptor → signalling pathway → cellular response → physiological effect.

What that response actually is depends entirely on which peptide and which receptor. Sometimes it means releasing another hormone. Sometimes it affects gene expression, or enzyme activity, or a metabolic process. Sometimes the effect is quite local.

So when somebody says "this peptide increases X," the better question is how. What's the path between the molecule and the claim?

People use these two words almost interchangeably. They don't mean the same thing.

Peptide describes the molecule's structure. Hormone describes the job a molecule does — acting as a signal in the body.

Some hormones are peptides: insulin is a peptide hormone. But plenty of peptides are not hormones at all — they take part in local signalling without ever behaving like a classical hormone.

Three terms come up constantly, and all three are simpler than they sound.

Analog

An analog is a molecule designed to resemble another one, with deliberate structural differences. Take the original design, change something — how long it lasts, how strongly it meets a receptor, how well it survives in the body.

An analog is not automatically "better." It's altered.

Agonist and antagonist

If a receptor is a lock, an agonist is something that turns it on. An antagonist blocks it instead. And there are degrees in between, which is why you'll see full agonist and partial agonist.

These words describe how a molecule meets a receptor. They don't mean good or bad.

This is a good example of why pathways matter more than names. Very simplified:

Hypothalamus → pituitary → growth hormone → liver and tissues → IGF-1.

The hypothalamus regulates the system. The pituitary releases growth hormone. Growth hormone acts on tissues throughout the body, and one downstream effect is IGF-1 production — another signalling molecule involved in growth.

So instead of "peptide = muscle," the honest version is a chain with several steps, multiple organs, and feedback loops along the way.

Secretagogue vs. giving the hormone

A secretagogue is something that stimulates the release of another substance. A growth-hormone secretagogue encourages your body to release its own growth hormone.

That is a different mechanism from supplying the hormone directly. One nudges the system. The other bypasses it.

Half-life is how long it takes for the amount of a substance in the body to fall by about half.

It matters because two molecules can touch the same pathway and behave completely differently — one clears quickly, the other stays around. That changes how something is studied and how often it's given.

But half-life is not the same as how long the effects last. Related, not identical.

Bioavailability

Bioavailability is how much of a substance actually reaches circulation in an active form.

This is why the route matters. Anything swallowed meets digestion and first-pass metabolism on the way, and peptides are particularly vulnerable to digestive enzymes — which is why so many peptide drugs have historically needed another route entirely.

Peptides are fragile by nature. The body is built to break molecules down: enzymes degrade them, the kidneys and liver clear them. That's exactly why researchers care so much about stability, clearance and structure.

Not all "research" carries the same weight. Roughly, from thinnest to strongest:

• Cell studies — useful for mechanism, but a dish is not a person
• Animal studies — more than a dish, still doesn't automatically translate
• Human observational — real people, limited control over what's happening
• Human clinical trials — controlled conditions, much stronger evidence
• Reviews and meta-analyses — many studies pooled, when the studies are good

So when you see "this peptide does X," the question isn't where do I get it. It's: what evidence supports that? In whom? For how long? What was actually measured? Was it even done in humans?

Peptide communities blend animal research, clinical research, personal anecdotes, mechanism speculation and marketing into one conversation. "I experienced X" and "a randomised trial found X" are both interesting. They are not the same claim.

If you're beginning, don't try to memorise fifty compounds. Ask the same few questions every time:

1. What is it — natural or synthetic?
2. What does it bind — which receptor, and where?
3. What pathway does that set off?
4. What evidence exists — cells, animals, or people?
5. What risks are known or suspected?

Once those are second nature, the rest of the vocabulary stops being noise.

The interesting part was never memorising names. It's understanding that a peptide is a molecule, a receptor is a target, a pathway is the communication system, and the biological response is the result. Everything else is detail hanging off that frame.

Which is where I'm starting with this journal. Not take this and expect that, but: what is this molecule, what does it interact with, and what does the evidence actually say?